DSGN
DSGN
NASDAQ · Biotechnology

Design Therapeutics Inc

$12.24
-0.57 (-4.45%)
As of Sep 20, 10:23 PM ET ·
DSGN News11 articles
Nintendo's Fire Emblem: Fortune's Weave Adopts Single-Save Design
Nintendo's Fire Emblem: Fortune's Weave launches Sept. 17 with a single-save system across routes, a design choice that could impact player engagement and software sales.
Analysis
Vicor Surges 11% on EV Battery Design Win, But Key Details Missing
Vicor shares rose 11% after INFAC's EV battery pack design using Vicor modules was disclosed, but the lack of commercial details raises questions about valuation.
Technology
Apple Watch Redesign Rumors Spotlight $7.9B Wearables Business
Apple is exploring a major Apple Watch redesign, according to Bloomberg's Mark Gurman. Wearables revenue reached $7.88B in Q3, up 6.5%, but growth lags overall company performance.
Technology
Hyundai Stock Slips 4.8% as Tucson Redesign Faces Margin Test
Hyundai shares dropped 4.8% after unveiling the new Tucson, which made up 23.9% of U.S. sales in July. The redesign could pressure margins as Q2 operating profit fell 20.8%.
Markets
MeiraGTx Stock Dips 5.5% After Weekly Slide; FDA Designation and Funding in Focus
MeiraGTx shares fell 5.5% Friday to $9.40, ending a 4.3% weekly drop, as the company reported a Q1 net loss of $46.3 million and advanced regulatory filings for key gene therapies.
Markets
Oklo Earnings in Focus After NRC Design Approval
Oklo Inc. reports Q1 earnings Tuesday, with analysts expecting a 19-cent loss, following NRC approval of key design criteria for its Aurora reactor.
Earnings
Oklo Gains NRC Approval for Aurora Design, but Commercial Hurdles Remain
Oklo Inc. received NRC approval for its Aurora powerhouse design, halving the review time. Yet, the company has no built plants or binding power deals, and faces significant hurdles.
Regulation
Figma Shares Rally 7% Ahead of Q1 Report Amid AI Design Competition
Figma shares jumped 7% to $20.08 ahead of its May 14 earnings report. Analysts remain cautious with a consensus 'Hold' rating, as AI rivals Anthropic and Google challenge the design software leader.
Earnings
Aterian Surges 89% on $18M Brand Sale and CEO-Designate Investment
Aterian Inc. shares surged 89% after the company agreed to sell its e-commerce brands for $18 million and secured a $7 million investment from David Lazar, who will become CEO.
Markets
Synopsys Deepens TSMC Alliance for AI Chip Design Tools
Synopsys announced expanded collaboration with TSMC on advanced chipmaking and packaging for AI, unveiling new design tools for 3nm, 2nm, A16, and A14 nodes. Shares rose to $483.00.
Technology
AWS Migrates Defense AI Work from Anthropic Following Pentagon Risk Designation
Amazon Web Services is moving defense-related AI workloads away from Anthropic's Claude model following a Pentagon supply-chain risk designation. The shift comes as Anthropic sues the government over the ban.
Regulation